Related Experiment Video
Updated: Sep 26, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study
Andreas Koster1, Derek Chew, Marcus Gründel
1Departments for *Anesthesia and †Thoracic and Cardiovascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany; ‡Department of Cardiology, Flinders Medical Center, South Australia, Australia; and §Department of Cardiothoracic Anesthesia, Virginia Commonwealth University, Richmond, Virginia.
Implications:
Bivalirudin is a new, direct thrombin inhibitor. We investigated the extracorporeal elimination rate of different hemofilters and one plasmapheresis filter for bivalirudin. Our data show that bivalirudin can be effectively eliminated via hemofiltration and plasmapheresis, although there were significant differences in the elimination rates among the filter systems investigated.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Continuous Renal Replacement Therapy
In Vitro Drug Dissolution: Compendial Testing Models I
Anticoagulant Drugs: Low-Molecular-Weight Heparins

